MICROPORT NEUROSCIENTIFIC CORPORATI revenue for the last year amounted to 732.27 M HKD, the most of which — 469.92 M HKD — came from its highest performing source at the moment, Hemorrhagic Stroke Products, the year earlier bringing 348.35 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought MICROPORT NEUROSCIENTIFIC CORPORATI 700.49 M HKD, and the year before that — 611.02 M HKD.